Cited by 125Cytomegalovirus and herpesvirus researchTransplantation: Methods and OutcomesViral-associated cancers and disorders

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

Mechanisms of Cytomegalovirus-Accelerated Vascular Disease: Induction of Paracrine Factors That Promote Angiogenesis and Wound Healing

Open access

Streblow, D. N., Dumortier, J., Moses, A. V., Orloff, S. L., Nelson, J. A.·2008·Current Topics in Microbiology and Immunology

DOI 10.1007/978-3-540-77349-8_22PMC PMC2699259

Open this paper in CoChat — free account

Abstract

Human cytomegalovirus (HCMV) is associated with the acceleration of a number of vascular diseases such as atherosclerosis, restenosis, and transplant vascular sclerosis (TVS). All of these diseases are the result of either mechanical or immune-mediated injury followed by inflammation and subsequent smooth muscle cell (SMC) migration from the vessel media to the intima and proliferation that culminates in vessel narrowing. A number of epidemiological and animal studies have demonstrated that CMV significantly accelerates TVS and chronic rejection (CR) in solid organ allografts. In addition, treatment of human recipients and animals alike with the antiviral drug ganciclovir results in prolonged survival of the allograft, indicating that CMV replication is a requirement for acceleration of disease. However, although virus persists in the allograft throughout the course of disease, the number of directly infected cells does not account for the global effects that the virus has on the acceleration of TVS and CR. Recent investigations of up- and downregulated cellular genes in infected allografts in comparison to native heart has demonstrated that rat CMV (RCMV) upregulates genes involved in wound healing (WH) and angiogenesis (AG). Consistent with this result, we have found that supernatants from HCMV-infected cells (HCMV secretome) induce WH and AG using in vitro models. Taken together, these findings suggest that one mechanism for HCMV acceleration of TVS is mediated through induction of secreted cytokines and growth factors from virus-infected cells that promote WH and AG in the allograft, resulting in the acceleration of TVS. We review here the ability of CMV infection to alter the local environment by producing cellular factors that act in a paracrine fashion to enhance WH and AG processes associated with the development of vascular disease, which accelerates chronic allograft rejection.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/978-3-540-77349-8_22

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

J Heart Lung Transplant 2021;40(4).
(2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.04.002 · Cited by 6,824
Angiogenesis in health and disease
Carmeliet, P. (2003) · Nature Medicine · doi:10.1038/nm0603-653 · Cited by 4,379
Regulation of Wound Healing by Growth Factors and Cytokines
WERNER, S., & GROSE, R. (2003) · Physiological Reviews · doi:10.1152/physrev.2003.83.3.835 · Cited by 3,629
Cytomegalovirus Infection Is Associated With Cardiac Allograft Rejection and Atherosclerosis
Grattan, M. T. (1989) · JAMA · doi:10.1001/jama.1989.03420240075030 · Cited by 966
Electric Cell–Substrate Impedance Sensing (ECIS) as a Noninvasive Means to Monitor the Kinetics of Cell Spreading to Artificial Surfaces
Wegener, J., Keese, C. R., & Giæver, I. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4919 · Cited by 773
Potential Role of Human Cytomegalovirus and p53 Interaction in Coronary Restenosis
Speir, E. H., Modali, R., Huang, E., Leon, M. B., Shawl, F. A., Finkel, T., & Epstein, S. E. (1994) · Science · doi:10.1126/science.8023160 · Cited by 753
Angiogenesis Assays: A Critical Overview
Auerbach, R., Lewis, R. L., Shinners, B., Kubai, L., & Akhtar, N. (2003) · Clinical Chemistry · doi:10.1373/49.1.32 · Cited by 705
Fundamental Concepts of the Angiogenic Process
Folkman, J. (2003) · Current Molecular Medicine · doi:10.2174/1566524033479465 · Cited by 666
The Human Cytomegalovirus Chemokine Receptor US28 Mediates Vascular Smooth Muscle Cell Migration
Streblow, D. N., Söderberg‐Nauclér, C., Vieira, J., Smith, P., Wakabayashi, E., Ruchti, F., Mattison, K., Altschuler, Y., & Nelson, J. A. (1999) · Cell · doi:10.1016/s0092-8674(00)81539-1 · Cited by 439
Self-citation
Electrical wound-healing assay for cells in vitro
Keese, C. R., Wegener, J., Walker, S. R., & Giæver, I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307588100 · Cited by 423

Show all 65 references

Research works printed but not linked: 1

Melnick JL, Adam E, DeBakey ME (1998) The link between CMV and atherosclerosis. Infect Med 15:479–486.

Sorted by citations

Cytomegalovirus Latency and Reactivation: An Intricate Interplay With the Host Immune Response
Forte, E., Zhang, Z., Thorp, E. B., & Hummel, M. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00130 · Cited by 284
Cytomegalovirus infection is associated with increased mortality in the older population
Savva, G. M., Pachnio, A., Kaul, B., Morgan, K., Huppert, F. A., Brayne, C., & Moss, P. A. H. (2013) · Aging Cell · doi:10.1111/acel.12059 · Cited by 216
Viral effects on metabolism: changes in glucose and glutamine utilization during human cytomegalovirus infection
Yu, Y., Clippinger, A. J., & Alwine, J. C. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.04.002 · Cited by 199
The Immune Response to Human CMV
Rosa, C. L., & Diamond, D. J. (2012) · Future Virology · doi:10.2217/fvl.12.8 · Cited by 190
Human Cytomegalovirus Induces Systemic Immune Activation Characterized by a Type 1 Cytokine Signature
van de Berg, P. J., Heutinck, K. M., Raabe, R., Minnee, R. C., Young, S. L., der Pant, K. A. M. I. V. D., Bemelman, F. J., van Lier, R. A. W., & ten Berge, I. J. M. (2010) · The Journal of Infectious Diseases · doi:10.1086/655472 · Cited by 182
Significant Association of Multiple Human Cytomegalovirus Genomic Loci with Glioblastoma Multiforme Samples
Ranganathan, P., Clark, P. A., Kuo, J. S., Salamat, M. S., & Kalejta, R. F. (2011) · Journal of Virology · doi:10.1128/jvi.06097-11 · Cited by 149
Human cytomegalovirus persistence
Goodrum, F. D., Caviness, K., & Zagallo, P. (2012) · Cellular Microbiology · doi:10.1111/j.1462-5822.2012.01774.x · Cited by 148
Human cytomegalovirus tropism for endothelial/epithelial cells: scientific background and clinical implications
Revello, M. G., & Gerna, G. (2010) · Reviews in Medical Virology · doi:10.1002/rmv.645 · Cited by 145
Memory T cell inflation: understanding cause and effect
O’Hara, G. A., Welten, S. P. M., Klenerman, P., & Arens, R. (2012) · Trends in Immunology · doi:10.1016/j.it.2011.11.005 · Cited by 137
Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodies
Kabanova, A., Perez, L. H., Lilleri, D., Marcandalli, J., Agatic, G., Becattini, S., Preite, S., Fuschillo, D., Percivalle, E., Sallusto, F., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415310111 · Cited by 119
Human CMV infection of endothelial cells induces an angiogenic response through viral binding to EGF receptor and β 1 and β 3 integrins
Bentz, G. L., & Yurochko, A. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800037105 · Cited by 118
Molecular Determinants and the Regulation of Human Cytomegalovirus Latency and Reactivation
Collins-McMillen, D. K., Buehler, J., Peppenelli, M. A., & Goodrum, F. D. (2018) · Viruses · doi:10.3390/v10080444 · Cited by 117
IL-6 in human cytomegalovirus secretome promotes angiogenesis and survival of endothelial cells through the stimulation of survivin
Botto, S., Streblow, D. N., DeFilippis, V. R., White, L., Kreklywich, C. N., Smith, P. P., & Caposio, P. (2010) · Blood · doi:10.1182/blood-2010-06-291245 · Cited by 114
Self-citation
Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything
Loewendorf, A. I., & Benedict, C. A. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02220.x · Cited by 110
Human Cytomegalovirus Glycoprotein UL141 Targets the TRAIL Death Receptors to Thwart Host Innate Antiviral Defenses
Smith, W., Tomašec, P., Aicheler, R., Loewendorf, A. I., Nemčovičová, I., Wang, E. C. Y., Stanton, R. J., Macauley, M., Norris, P. S., Willen, L., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.02.003 · Cited by 108
Overview of Human Cytomegalovirus Pathogenesis
Fulkerson, H. L., Nogalski, M. T., Collins-McMillen, D. K., & Yurochko, A. D. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1111-1_1 · Cited by 103
Fatty Acid Elongase 7 Catalyzes Lipidome Remodeling Essential for Human Cytomegalovirus Replication
Purdy, J. G., Shenk, T., & Rabinowitz, J. D. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.02.003 · Cited by 103
Overview of Human Cytomegalovirus Pathogenesis
Nogalski, M. T., Collins-McMillen, D. K., & Yurochko, A. D. (2014) · Methods in molecular biology · doi:10.1007/978-1-62703-788-4_2 · Cited by 105
Herpesvirus‐bacteria synergistic interaction in periodontitis
Chen, C., Feng, P., & Slots, J. (2019) · Periodontology 2000 · doi:10.1111/prd.12311 · Cited by 104
PI3K-Dependent Upregulation of Mcl-1 by Human Cytomegalovirus Is Mediated by Epidermal Growth Factor Receptor and Inhibits Apoptosis in Short-Lived Monocytes
Chan, G. C. T., Nogalski, M. T., Bentz, G. L., Smith, M. S., Parmater, A., & Yurochko, A. D. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903025 · Cited by 100
Latent Cytomegalovirus infection amplifies CD8 T-lymphocyte mobilisation and egress in response to exercise
Turner, J. E., Aldred, S., Witard, O. C., Drayson, M. T., Moss, P. M., & Bosch, J. A. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.07.239 · Cited by 90
Increased Expression of LDL Receptor-Related Protein 1 during Human Cytomegalovirus Infection Reduces Virion Cholesterol and Infectivity
Gudleski-O'Regan, N., Greco, T. M., Cristea, I. M., & Shenk, T. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.05.012 · Cited by 84
Multifaceted Evasion of the Interferon Response by Cytomegalovirus
Marshall, E. E., & Geballe, A. P. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2009.0064 · Cited by 81
Cytomegalovirus promotes murine glioblastoma growth via pericyte recruitment and angiogenesis
Krenzlin, H., Behera, P., Lorenz, V., Passaro, C., Zdioruk, M. I., Nowicki, M. O., Grauwet, K., Zhang, H., Skubal, M., Ito, H., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci123375 · Cited by 79
The role of cytomegalovirus in angiogenesis
Caposio, P., Orloff, S. L., & Streblow, D. N. (2010) · Virus Research · doi:10.1016/j.virusres.2010.09.011 · Cited by 80
Self-citation
N2O2‐chelate metal complexes with Schiff base ligand: Synthesis, characterisation and contribution as a promising antiviral agent against human cytomegalovirus
El‐Hamid, S. M. A., Sadeek, S. A., Mohammed, S. F., Ahmed, F. M., & El‐Gedamy, M. S. (2022) · Applied Organometallic Chemistry · doi:10.1002/aoc.6958 · Cited by 75
The Cell Biology of Cytomegalovirus: Implications for Transplantation
Kaminski, H., & Fishman, J. A. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13791 · Cited by 77
Human Cytomegalovirus UL29/28 Protein Interacts with Components of the NuRD Complex Which Promote Accumulation of Immediate-Early RNA
Terhune, S. S., Moorman, N. J., Cristea, I. M., Savaryn, J. P., Cuevas-Bennett, C., Rout, M. P., Chait, B. T., & Shenk, T. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000965 · Cited by 70
The Impact of Mass Spectrometry–Based Proteomics on Fundamental Discoveries in Virology
Greco, T. M., Diner, B. A., & Cristea, I. M. (2014) · Annual Review of Virology · doi:10.1146/annurev-virology-031413-085527 · Cited by 67
“Considering recent evidence implicating angiogenesis in HCMV-associated vasculopathies (128), Dumortier et al.”
Background
Humanized mouse models of human cytomegalovirus infection
Crawford, L. B., Streblow, D. N., Hakki, M., Nelson, J. A., & Caposio, P. (2015) · Current Opinion in Virology · doi:10.1016/j.coviro.2015.06.006 · Cited by 64
Self-citation
Human Cytomegalovirus IE1 Protein Elicits a Type II Interferon-Like Host Cell Response That Depends on Activated STAT1 but Not Interferon-γ
Knoblach, T., Grandel, B., Seiler, J., Nevels, M. M., & Paulus, C. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002016 · Cited by 62
Human Cytomegalovirus Stimulates Monocyte-to-Macrophage Differentiation via the Temporal Regulation of Caspase 3
Chan, G. C. T., Nogalski, M. T., & Yurochko, A. D. (2012) · Journal of Virology · doi:10.1128/jvi.07129-11 · Cited by 61
Immune Landscape of CMV Infection in Cancer Patients: From “Canonical” Diseases Toward Virus-Elicited Oncomodulation
Baba, R. E., & Herbein, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.730765 · Cited by 67
Postnatally acquired cytomegalovirus infection in preterm infants: a prospective study on risk factors and cranial ultrasound findings
Nijman, J., de Vries, L. S., Koopman-Esseboom, C., Uiterwaal, C. S. P. M., van Loon, A. M., & Verboon-Maciolek, M. A. (2012) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/archdischild-2011-300405 · Cited by 59
US28: HCMV’s Swiss Army Knife
Krishna, B. A., Miller, W. E., & O’Connor, C. M. (2018) · Viruses · doi:10.3390/v10080445 · Cited by 58
Cytomegalovirus is a tumor-associated virus: armed and dangerous
Cobbs, C. (2019) · Current Opinion in Virology · doi:10.1016/j.coviro.2019.08.003 · Cited by 57
Essential role of HCMV deubiquitinase in promoting oncogenesis by targeting anti-viral innate immune signaling pathways
Kumari, P., Saha, I., Narayanan, A., Narayanan, S., Takaoka, A., Kumar, N. S., Tailor, P. B., & Kumar, H. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.461 · Cited by 54
Emerging Role of Compartmentalized G Protein-Coupled Receptor Signaling in the Cardiovascular Field
Plouffe, B., Thomsen, A. R. B., & Irannejad, R. (2020) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.0c00006 · Cited by 47
Respiratory infections in immunocompromised patients
Corti, M., Palmero, D., & Eiguchi, K. (2009) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e328329bd2c · Cited by 51
Developing a Vaccine Against Congenital CMV Infection: What have we Learned from Animal Models? Where should we go Next?
Schleiss, M. R. (2013) · Future Virology · doi:10.2217/fvl.13.106 · Cited by 49
An association between cytomegalovirus infection and pre‐eclampsia: a case–control study and data synthesis
Xie, F., Hu, Y., Magee, L. A., Money, D., Patrick, D. M., Krajden, M., Thomas, É., & von Dadelszen, P. (2010) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016349.2010.499449 · Cited by 48
In vivo impact of cytomegalovirus evasion of CD8 T-cell immunity: Facts and thoughts based on murine models
Lemmermann, N. A. W., Böhm, V., Holtappels, R., & Reddehase, M. J. (2010) · Virus Research · doi:10.1016/j.virusres.2010.09.022 · Cited by 46
Incidence of Cytomegalovirus Infection in Shanghai, China
Fang, F., Fan, Q., Yang, Z.-J., Peng, Y., Zhang, L., Mao, K.-Z., Zhang, Y., & Ji, Y. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00385-08 · Cited by 46
MicroRNA-217 Promotes Angiogenesis of Human Cytomegalovirus-Infected Endothelial Cells through Downregulation of SIRT1 and FOXO3A
Zhang, S., Liu, L., Wang, R.-J., Tuo, H., Guo, Y., Li, Y., Wang, D., & Wang, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083620 · Cited by 45
Early inhibitors of human cytomegalovirus: State-of-art and therapeutic perspectives
Mercorelli, B., Lembo, D., Palù, G., & Loregian, A. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.04.007 · Cited by 44
Human cytomegalovirus productively infects lymphatic endothelial cells and induces a secretome that promotes angiogenesis and lymphangiogenesis through interleukin-6 and granulocyte-macrophage colony-stimulating factor
Fiorentini, S., Luganini, A., Dell’Oste, V., Lorusso, B., Cervi, E., Caccuri, F., D, S. B. M., Landolfo, S., Caruso, A., & Gribaudo, G. (2010) · Journal of General Virology · doi:10.1099/vir.0.025395-0 · Cited by 44
Human Cytomegalovirus Immediate-Early 1 Protein Rewires Upstream STAT3 to Downstream STAT1 Signaling Switching an IL6-Type to an IFNγ-Like Response
Harwardt, T., Lukas, S., Zenger, M., Reitberger, T., Danzer, D., Theresa, Ü., Munday, D. C., Nevels, M. M., & Paulus, C. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005748 · Cited by 43
Cytomegalovirus MicroRNA Expression Is Tissue Specific and Is Associated with Persistence
Meyer, C., Grey, F. E., Kreklywich, C. N., Andoh, T. F., Tirabassi, R. S., Orloff, S. L., & Streblow, D. N. (2010) · Journal of Virology · doi:10.1128/jvi.01900-10 · Cited by 44
Self-citation
Human Cytomegalovirus UL135 and UL136 Genes Are Required for Postentry Tropism in Endothelial Cells
Bughio, F., Umashankar, M., Wilson, J. M., & Goodrum, F. D. (2015) · Journal of Virology · doi:10.1128/jvi.00284-15 · Cited by 40
Cytomegalovirus Latency Promotes Cardiac Lymphoid Neogenesis and Accelerated Allograft Rejection in CMV Naïve Recipients
Orloff, S. L., Hwee, Y.-K., Kreklywich, C. N., Andoh, T. F., Hart, E., Smith, P. A., Messaoudi, I., & Streblow, D. N. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03365.x · Cited by 42
Self-citation
Macrophage Activation Associated with Chronic Murine Cytomegalovirus Infection Results in More Severe Experimental Choroidal Neovascularization
Cousins, S. W., Espinosa‐Heidmann, D. G., Miller, D. M., Pereira‐Simon, S., Hernandez, E. P., Chien, H., Meier-Jewett, C. L., & Dix, R. D. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002671 · Cited by 40
Seroprevalence of 13 common pathogens in a rapidly growing U.S. minority population: Mexican Americans from San Antonio, TX
Rubicz, R. C., Leach, C. T., Kraig, E., Dhurandhar, N. V., Grubbs, B. G., Blangero, J., Yolken, R. H., & Göring, H. H. H. (2011) · BMC Research Notes · doi:10.1186/1756-0500-4-433 · Cited by 38
Persistent Infection of Human Fetal Endothelial Cells with Rubella Virus
Perelygina, L. M., Zheng, Q., Metcalfe, M. G., & Icenogle, J. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073014 · Cited by 37
MiR-199a-5p promotes migration and tube formation of human cytomegalovirus-infected endothelial cells through downregulation of SIRT1 and eNOS
Zhang, S., Liu, L., Wang, R., Tuo, H., Guo, Y., Li, Y., Wang, J., & Wang, D. (2013) · Archives of Virology · doi:10.1007/s00705-013-1744-1 · Cited by 36
Human Cytomegalovirus Stimulates the Synthesis of Select Akt-Dependent Antiapoptotic Proteins during Viral Entry To Promote Survival of Infected Monocytes
Peppenelli, M. A., Arend, K. C., Cojohari, O., Moorman, N. J., & Chan, G. C. T. (2016) · Journal of Virology · doi:10.1128/jvi.02879-15 · Cited by 36
Rodent Models of Congenital Cytomegalovirus Infection
Cekinović, Đ., Lisnić, V. J., & Jonjić, S. (2014) · Methods in molecular biology · doi:10.1007/978-1-62703-788-4_16 · Cited by 36
Predictors of severity for postnatal cytomegalovirus infection in preterm infants and implications for treatment
Gunkel, J., Wolfs, T. F. W., de Vries, L. S., & Nijman, J. (2014) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.2014.966080 · Cited by 34
Cytomegalovirus
Britt, W. J. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-6400-8.00023-7 · Cited by 33
Human cytomegalovirus pUL37x1-induced calcium flux activates PKCα, inducing altered cell shape and accumulation of cytoplasmic vesicles
Sharon-Friling, R., & Shenk, T. E. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402515111 · Cited by 32
Nuclear Localization of Tegument-Delivered pp71 in Human Cytomegalovirus-Infected Cells Is Facilitated by One or More Factors Present in Terminally Differentiated Fibroblasts
Penkert, R. R., & Kalejta, R. F. (2010) · Journal of Virology · doi:10.1128/jvi.00500-10 · Cited by 29
Bioactive Molecules Released From Cells Infected with the Human Cytomegalovirus
Luganini, A., Terlizzi, M. E., & Gribaudo, G. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00715 · Cited by 29
Insights into novel inhibitors intending HCMV protease a computational molecular modelling investigation for antiviral drug repurposing
Siddiquee, N. H., Tanni, A. A., Sarker, N., Sourav, S. H., Islam, L., Mili, M. A., Akter, F., Roy, S. C., Abdullah-Al-Mamun, M., Malek, S., et al. (2024) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2024.101522 · Cited by 27
Reverse Genetics Modification of Cytomegalovirus Antigenicity and Immunogenicity by CD8 T‐Cell Epitope Deletion and Insertion
Lemmermann, N. A. W., Kropp, K. A., Seckert, C. K., Grzimek, N. K. A., & Reddehase, M. J. (2010) · BioMed Research International · doi:10.1155/2011/812742 · Cited by 28
Cytomegalovirus Prevention and Long-Term Recipient and Graft Survival in Pediatric Heart Transplant Recipients
Snydman, D. R., Kistler, K. D., Ulsh, P. J., & Morris, J. A. (2010) · Transplantation · doi:10.1097/tp.0b013e3181ffba7e · Cited by 27
Antitreponemal Antibodies Leading to Autoantibody Production and Protection from Atherosclerosis in Kitavans from Papua New Guinea
Agmon‐Levin, N., Bat‐sheva, P. K., Barzilai, O., Ram, M., Lindeberg, S., Frostegård, J., & Shoenfeld, Y. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04671.x · Cited by 26
A Permanently Growing Human Endothelial Cell Line Supports Productive Infection With Human Cytomegalovirus Under Conditional Cell Growth Arrest
Lieber, D., Hochdorfer, D., Stöhr, D., Schubert, A., Lotfi, R., May, T., Wirth, D., & Sinzger, C. (2015) · BioTechniques · doi:10.2144/000114326 · Cited by 26
Cytomegalovirus antivirals and development of improved animal models
McGregor, A., & Choi, K. Y. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.613824 · Cited by 25
Repurposing the clinically approved calcium antagonist manidipine dihydrochloride as a new early inhibitor of human cytomegalovirus targeting the Immediate-Early 2 (IE2) protein
Mercorelli, B., Luganini, A., Celegato, M., Palù, G., Gribaudo, G., & Loregian, A. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.12.014 · Cited by 24
Control of Immediate Early Gene Expression for Human Cytomegalovirus Reactivation
Collins-McMillen, D. K., Kamil, J. P., Moorman, N. J., & Goodrum, F. D. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00476 · Cited by 24
Cell Type-Specific Biogenesis of Novel Vesicles Containing Viral Products in Human Cytomegalovirus Infection
Momtaz, S., Molina, B., Mlera, L., Goodrum, F. D., & Wilson, J. M. (2021) · Journal of Virology · doi:10.1128/jvi.02358-20 · Cited by 21
Human Cytomegalovirus Infection Leads to Elevated Levels of Transplant Arteriosclerosis in a Humanized Mouse Aortic Xenograft Model
Abele-Ohl, S., Leis, M., Wollin, M., Mahmoudian, S., Hoffmann, J., Müller, R., Heim, C., Spriewald, B. M., Weyand, M., Stamminger, T., et al. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04018.x · Cited by 21
Herpes viruses and tumours in kidney transplant recipients. The role of immunosuppression
Ponticelli, C. E. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr157 · Cited by 21
Association of Cytomegalovirus End-Organ Disease with Stroke in People Living with HIV/AIDS: A Nationwide Population-Based Cohort Study
Yen, Y., Jen, I.-A., Chen, M., Chuang, P., Liu, Y.-L., Sharp, G. B., & Chen, Y. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151684 · Cited by 20
Viruses and Metabolism
Yu, Y., Clippinger, A. J., Pierciey, F. J., & Alwine, J. C. (2011) · Advances in virus research · doi:10.1016/b978-0-12-385987-7.00003-8 · Cited by 20
Murine Cytomegalovirus Infection Leads to Increased Levels of Transplant Arteriosclerosis in a Murine Aortic Allograft Model
Heim, C., Abele-Ohl, S., Eckl, S., Ramsperger-Gleixner, M., Mahmoudian, S., Weyand, M., Stamminger, T., & Ensminger, S. M. (2010) · Transplantation · doi:10.1097/tp.0b013e3181e8a699 · Cited by 19
miR-138 promotes migration and tube formation of human cytomegalovirus-infected endothelial cells through the SIRT1/p-STAT3 pathway
Zhang, S., Liu, L., Wang, R., Tuo, H., Guo, Y., Li, Y., Wang, D., & Wang, J. (2017) · Archives of Virology · doi:10.1007/s00705-017-3423-0 · Cited by 18
Human cytomegalovirus increases HUVEC sensitivity to thrombin and modulates expression of thrombin receptors
Popović, M., Paskaš, S., Živković, M., Burýšek, L., & Laumonnier, Y. (2010) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-010-0447-7 · Cited by 17
Efficiency of porcine endothelial cell infection with human cytomegalovirus depends on both virus tropism and endothelial cell vascular origin
Millard, A., Haeberli, L., Sinzger, C., Ghielmetti, M., Schneider, M. K. J., Bossart, W., Seebach, J. D., & Mueller, N. J. (2010) · Xenotransplantation · doi:10.1111/j.1399-3089.2010.00594.x · Cited by 16
The Human Cytomegalovirus UL116 Glycoprotein Is a Chaperone to Control gH-Based Complexes Levels on Virions
Vezzani, G., Amendola, D., Yu, D. L., Chandramouli, S., Frigimelica, E., Maione, D., & Merola, M. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.630121 · Cited by 15
Human cytomegalovirus infection of THP-1 derived macrophages reveals strain-specific regulation of actin dynamics
Sánchez, V., Dong, J. J., Battley, J., Jackson, K. N., & Dykes, B. C. (2012) · Virology · doi:10.1016/j.virol.2012.07.015 · Cited by 14
Human cytomegalovirus and Epstein–Barr virus infections occurring early after transplantation are risk factors for antibody-mediated rejection in heart transplant recipients
Saldan, A., Mengoli, C., Sgarabotto, D., Fedrigo, M., Angelini, A., Feltrin, G., Gambino, A., Gerosa, G., Barzon, L., & Abate, D. A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1171197 · Cited by 13
Lymphotropic herpesvirus DNA detection in patients with active CMV infection – a possible role in the course of CMV infection after hematopoietic stem cell transplantation
Zawilińska, B., Kopeć, J., Szostek, S., Piątkowska‐Jakubas, B., Skotnicki, A. B., & Kosz‐Vnenchak, M. (2011) · Medical Science Monitor · doi:10.12659/msm.881904 · Cited by 13
Establishment of rat brain endothelial cells susceptible to rat cytomegalovirus ALL-03 infection
Camalxaman, S.-N., Zeenathul, N. A., Quah, Y. W., Loh, H., Zuridah, H., Hani, H., Sheikh-Omar, A. R., & Lila, M. A. M. (2013) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-012-9553-5 · Cited by 13
Subcellular quantitative proteomic analysis reveals host proteins involved in human cytomegalovirus infection
Chai, F., Li, H., Wang, W., Zhu, X., Li, Y., Wang, S., Guo, L., Zhang, L., & Xiao, G. (2015) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2015.04.016 · Cited by 13
How can pathologists help to diagnose late complications in small bowel and multivisceral transplantation?
Ruiz, P. (2012) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0b013e3283534eb0 · Cited by 13
Interaction Network of Proteins Associated with Human Cytomegalovirus IE2-p86 Protein during Infection: A Proteomic Analysis
Du, G., & Stinski, M. F. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081583 · Cited by 12
Differential effects on nitric oxide-mediated vasodilation in mesenteric and uterine arteries from cytomegalovirus-infected mice
Gombos, R. B., & Hemmings, D. G. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01113.2009 · Cited by 12
Therapeutic targeting of HCMV-encoded chemokine receptor US28: Progress and challenges
Berg, C., & ROSENKILDE, M. M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1135280 · Cited by 11
Supra‐Additive Expression of Interleukin‐6, Interleukin‐8 and Basic Fibroblast Growth Factor in Vascular Smooth Muscle Cells Following Coinfection with Chlamydia pneumoniae and Cytomegalovirus as a Novel Link between Infection and Atherosclerosis
Prochnau, D., Straube, E., Figulla, H., & Rödel, J. (2012) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2012/987476 · Cited by 11
Human cytomegalovirus inhibits apoptosis involving upregulation of the antiapoptotic protein Bag‐1
Li, H. P., Yuan, C. L., & Zho, Y. C. (2015) · Journal of Medical Virology · doi:10.1002/jmv.24259 · Cited by 10
Virus-Encoded 7 Transmembrane Receptors
Mølleskov-Jensen, A.-S., Oliveira, M. T., Farrell, H. E., & Davis-Poynter, N. J. (2014) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2014.10.010 · Cited by 10
Human Herpesviruses and Animal Models
McGregor, A., Choi, K. Y., Schachtele, S. J., & Lokensgard, J. R. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415894-8.00037-3 · Cited by 9
A Systemic Network Triggered by Human Cytomegalovirus Entry
Wang, A., Ren, L., & Li, H. (2011) · Advances in Virology · doi:10.1155/2011/262080 · Cited by 8
Increased Osteoprotegerin Predicts Poor Virological Outcome During Anticytomegalovirus Therapy in Solid Organ Transplant Recipients
Ueland, T., Rollag, H., Hartmann, A., Jardine, A. G., Humar, A., Bignamini, A. A., Åsberg, A., & Aukrust, P. (2014) · Transplantation · doi:10.1097/tp.0000000000000227 · Cited by 8
Human cytomegalovirus immediate early protein 2 enhances myocardin-mediated survival of rat aortic smooth muscle cells
Liao, X., Dong, X., Wu, C., Wang, T., Liu, F., Zhou, J., & Zhang, T. (2014) · Virus Research · doi:10.1016/j.virusres.2014.08.007 · Cited by 8
The Contribution of Cytomegalovirus to Atherosclerotic Events after Kidney Transplantation
Shimamura, M. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit065 · Cited by 8
A Method for Quantifying Mechanical Properties of Tissue following Viral Infection
Lam, V., Bigley, T. M., Terhune, S. S., & Wakatsuki, T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042197 · Cited by 7
Embracing the heterogeneity of natural viruses in mouse studies
Fiege, J. K., & Langlois, R. A. (2022) · Journal of General Virology · doi:10.1099/jgv.0.001758 · Cited by 6
Dual-color bioluminescent assay using infected HepG2 cells sheds new light on Chlamydia pneumoniae and human cytomegalovirus effects on human cholesterol 7α-hydroxylase (CYP7A1) transcription
Michelini, E., Donati, M., Aldini, R., Cevenini, L., Mezzanotte, L., Nardini, P., Foschi, C., Zvi, I. B., Cevenini, M., Montagnani, M., et al. (2012) · Analytical Biochemistry · doi:10.1016/j.ab.2012.08.003 · Cited by 6
The Oncogenicity of Human Cytomegalovirus
Vishnu, P., & David, M. (2013) · InTech eBooks · doi:10.5772/55051 · Cited by 5

Authors: Streblow, D. N., Dumortier, J., Moses, A. V., Orloff, S. L., & Nelson, J. A.
Affiliations: Oregon Health & Science University (US)
Corresponding author: Streblow, D. N.
ORCID: Streblow, D. N.
Moses, A. V.
Orloff, S. L.
Nelson, J. A.
Venue: Current Topics in Microbiology and Immunology
Publisher: Springer Berlin Heidelberg
Published: 2008
Volume: 325
Pages: 397-415
ISSN: 0070-217X (ISSN-L)
DOI: 10.1007/978-3-540-77349-8_22
PMC: PMC2699259
OpenAlex: W125742586
Cited by: 125
References: 65
Citations by year: 2026: 2 · 2025: 1 · 2024: 3 · 2023: 2 · 2022: 3 · 2021: 5 · 2020: 3 · 2019: 3 · 2018: 6 · 2017: 4 · 2016: 8 · 2015: 6 · 2014: 10 · 2013: 11 · 2012: 15
FWCI: 38.67
Type: book chapter
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Current topics in microbiology and immunology (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: U.S. Department of Veterans Affairs
American Heart Association
National Institutes of Health
National Heart, Lung, and Blood Institute (HL 66238-01, R01HL083194, R01HL071695, HL 083194, R01HL065754, HL65754, R01HL085451, HL71695, R01HL066238, R01HL088603)
National Institute of Allergy and Infectious Diseases (AI21640, R37AI021640, R01AI021640)
Topics: Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
Keywords: human cytomegalovirus, vascular disease, chronic rejection, angiogenesis, wound healing, paracrine signaling, secretome, cytokines and growth factors, rat cytomegalovirus, atherosclerosis, restenosis, smooth muscle cell proliferation, ganciclovir
MeSH terms: Animals, Cytomegalovirus Infections, Cytomegalovirus, Humans, Sclerosis, Vascular Diseases, Cytokines, Intercellular Signaling Peptides and Proteins, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mechanisms of Cytomegalovirus-Accelerated Vascular Disease: Induction of Paracrine Factors That Promote Angiogenesis and Wound Healing

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks